Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy
Clinical trial NCT05796089 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05796089
- Sponsor
- Trans Tasman Radiation Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2027-09-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.